positive
Allotment process begins for heavily subscribed Sudeep Pharma IPO
Share allocation for the Sudeep Pharma IPO is scheduled to be finalised today following exceptionally strong demand during the three day subscription period that closed on November 25. The public issue recorded an overall subscription of 93.71 times, driven by notably high participation across investor categories. Retail investors subscribed 15.65 times, while non-institutional bidders reached 116.72 times
Companies:
- Sudeep Pharma
Tags:
- ipo
- markets
Bseindia• By Pooja Kumari
Explore:High Return Equity Mutual Fund
positive
Allotment process begins for heavily subscribed Sudeep Pharma IPO
Share allocation for the Sudeep Pharma IPO is scheduled to be finalised today following exceptionally strong demand during the three day subscription period that closed on November 25. The public issue recorded an overall subscription of 93.71 times, driven by notably high participation across investor categories. Retail investors subscribed 15.65 times, while non-institutional bidders reached 116.72 times
Companies:
- Sudeep Pharma
Tags:
- ipo
- markets
Bseindia• By Pooja Kumari
Explore:High Return Equity Mutual Fund
1 min read
57 words
Sudeep Pharma’s IPO allotment is being finalised after strong demand pushed overall subscription to 93.71 times, led by exceptional QIB participation and broad interest across investor categories.
Share allocation for the Sudeep Pharma IPO is scheduled to be finalised today following exceptionally strong demand during the three day subscription period that closed on November 25. The public issue recorded an overall subscription of 93.71 times, driven by notably high participation across investor categories. Retail investors subscribed 15.65 times, while non-institutional bidders reached 116.72 times
Share allocation for the Sudeep Pharma IPO is scheduled to be finalised today following exceptionally strong demand during the three day subscription period that closed on November 25. The public issue recorded an overall subscription of 93.71 times, driven by notably high participation across investor categories. Retail investors subscribed 15.65 times, while non-institutional bidders reached 116.72 times
Companies:
- Sudeep Pharma
Tags:
- ipo
- markets
- ipo
- markets
- india
- pharma